IL78696A - Synthetic peptide and process of using same for the detection of antibodies of htlv-iii,diagnosis of aids and pre-aids conditions and as a vaccine - Google Patents

Synthetic peptide and process of using same for the detection of antibodies of htlv-iii,diagnosis of aids and pre-aids conditions and as a vaccine

Info

Publication number
IL78696A
IL78696A IL78696A IL7869686A IL78696A IL 78696 A IL78696 A IL 78696A IL 78696 A IL78696 A IL 78696A IL 7869686 A IL7869686 A IL 7869686A IL 78696 A IL78696 A IL 78696A
Authority
IL
Israel
Prior art keywords
aids
htlv
vaccine
antibodies
diagnosis
Prior art date
Application number
IL78696A
Other languages
English (en)
Other versions
IL78696A0 (en
Inventor
Yi Wang Chang
Jian Guang Wang James
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/847,102 external-priority patent/US4735896A/en
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of IL78696A0 publication Critical patent/IL78696A0/xx
Publication of IL78696A publication Critical patent/IL78696A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL78696A 1985-09-11 1986-05-06 Synthetic peptide and process of using same for the detection of antibodies of htlv-iii,diagnosis of aids and pre-aids conditions and as a vaccine IL78696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77464485A 1985-09-11 1985-09-11
US83756686A 1986-03-04 1986-03-04
US06/847,102 US4735896A (en) 1986-03-04 1986-04-02 Synthetic peptide and process of using same for the detection and diagnosis of AIDS and pre-AIDS conditions

Publications (2)

Publication Number Publication Date
IL78696A0 IL78696A0 (en) 1986-08-31
IL78696A true IL78696A (en) 1991-04-15

Family

ID=27419712

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78696A IL78696A (en) 1985-09-11 1986-05-06 Synthetic peptide and process of using same for the detection of antibodies of htlv-iii,diagnosis of aids and pre-aids conditions and as a vaccine

Country Status (9)

Country Link
EP (1) EP0214709B1 (de)
JP (1) JP2702911B2 (de)
AU (1) AU579467B2 (de)
DE (2) DE3689097T2 (de)
DK (1) DK198086A (de)
ES (1) ES8801839A1 (de)
HK (1) HK95194A (de)
IL (1) IL78696A (de)
NO (1) NO176798C (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
ATE98376T1 (de) * 1986-03-24 1993-12-15 Ortho Pharma Corp Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0247557B1 (de) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV)Decke-Peptide
US4943627A (en) * 1986-06-12 1990-07-24 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US5017688A (en) * 1986-06-12 1991-05-21 Biogen, Inc. Peptides involved in the pathogenesis of HIV infection
US5087557A (en) * 1986-06-23 1992-02-11 Genetic Systems Corporation Human monoclonal antibody to lymphadenopathy-associated virus
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
AU7786387A (en) * 1986-07-21 1988-02-10 Southwest Foundation For Biomedical Research Composition of matter and method of immunizing against viral causative agents of aids and arc
FR2610632B1 (fr) * 1987-02-11 1990-12-21 Pasteur Institut Peptides caracteristiques des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
ATE108457T1 (de) * 1987-03-25 1994-07-15 Genetic Systems Corp Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
AU1711888A (en) * 1987-04-24 1988-12-02 Biogen, Inc. Immunotherapeutic methods and compositions
US4921787A (en) * 1987-05-01 1990-05-01 Cambridge Bioscience Corporation Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5854400A (en) * 1987-05-29 1998-12-29 Tanox, Inc. Monoclonal antibodies which neutralize HIV-1 infection
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (de) * 1987-12-24 1990-07-25 The University Of Melbourne Antivirale Verbindungen und Methoden
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US5149623A (en) * 1988-02-09 1992-09-22 Virotest, Inc. Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
AU608413B2 (en) * 1988-03-30 1991-03-28 Abbott Laboratories Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
JPH0292298A (ja) * 1988-09-30 1990-04-03 Olympus Optical Co Ltd Ｈｉｖ構成蛋白に対するモノクローナル抗体
IL94558A0 (en) * 1989-06-06 1991-03-10 Merck & Co Inc Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
US6248574B1 (en) * 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
ATE185350T1 (de) * 1990-12-14 1999-10-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
US7119182B1 (en) 1991-02-19 2006-10-10 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
NZ552298A (en) 2004-05-23 2011-04-29 Gerard M Housey Method for identifying inhibitors or activators of a theramutein by comparing the phenoresponse of cells exposed to a test compound
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
CN102146116B (zh) * 2010-12-30 2013-02-13 桂林医学院 罗汉果甜苷v特异性抗血清的制备及检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63224A (en) * 1980-07-17 1985-05-31 Scripps Clinic Res Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
US5063150A (en) * 1984-09-19 1991-11-05 The Regents Of The University Of California Retroviral polypeptides associated with human cellular transformation
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
KR910002374B1 (ko) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Aids 관련질병의 검출을 위한 합성항원

Also Published As

Publication number Publication date
EP0214709B1 (de) 1993-09-29
AU579467B2 (en) 1988-11-24
HK95194A (en) 1994-09-16
ES554592A0 (es) 1988-02-16
NO861697L (no) 1987-03-12
EP0214709A2 (de) 1987-03-18
DE3689097D1 (de) 1993-11-04
JPS6261996A (ja) 1987-03-18
NO176798B (no) 1995-02-20
DK198086A (da) 1987-03-12
ES8801839A1 (es) 1988-02-16
DE214709T1 (de) 1987-10-15
DE3689097T2 (de) 1994-04-21
EP0214709A3 (en) 1988-09-21
NO176798C (no) 1995-05-31
AU5680386A (en) 1987-04-16
DK198086D0 (da) 1986-04-30
IL78696A0 (en) 1986-08-31
JP2702911B2 (ja) 1998-01-26

Similar Documents

Publication Publication Date Title
AU579467B2 (en) Synthetic peptide and process of using same for detection of antibodies to HTLV-III, diagnosis of AIDS and pre-AIDS conditions, and as a vaccine
AU589732B2 (en) Process for the preparation of 2-oxo-1,3-dioxolanes
LTIP1793A (en) Method for detecting antibodies against hiv virus
AU1380788A (en) Synthetic peptide antigens for the detection of hiv-1 infection
EP0261224A4 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
PT87510A (pt) A process for the preparation of polyimida gas separation membranes
YU165486A (en) Process for obtaining vaccine against aids
GR861099B (en) Synthetic antigen for the detection of aids-related disease
NO166522C (no) Fremgangsmaate for aa forbedre den mekaniske styrke av et finerark.
HUT44619A (en) Process for preparing monoclonal antibodies and peptides suitable for the treatment and detection of hiv infections
DE3779831D1 (de) Vorrichtung zum befestigen von einem paar kleiderverschlusselementen.
PT86091A (en) Process for the preparation of novel peptides
OA09026A (en) Method for detecting antibodies to human immunodeficiency virus.
KR870007837U (ko) 가방용 스냅-피트 콜래스프 파스너
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
DE3662970D1 (en) Improved blood-purifying membrane and process for preparation thereof
SG83694G (en) Synthetic peptide and process of using same for the detection of antibodies to HTLV-III, diagnosis of aids and pre-aids conditions and as a vaccine.
ZA878303B (en) A process for isolating and characterizing a new viral agent and its associated antigen,the antigen and viral agent obtained by this process,and detection procedures for non a,non b hepatitis using suitable immunological reagents
EP0119259A4 (de) Nicht a, nicht b, hepatitis-virus, verfahren zur bestimmung, reinigung, kennzeichnung, diagnose und immunisierung.
ZA882095B (en) Synthetic peptide antigens for the detection of hiv-1 infection
FR2609047B1 (fr) Procede de preparation de l-valine
RO91514A2 (ro) Procedeu de preparare a n-(2,6-diclorfenil)-2-indolinonei
FR2608925B1 (fr) Composition de polypeptides a action immunologique, son procede de preparation, et son utilisation pour la preparation de vaccins antipaludeens et de trousses de diagnostic pour la detection d'anticorps antimerozoaires
ZA892301B (en) Synthetic peptide antigens for the detection of htlv-1 infection
YU155987A (en) Process for obtaining n-(s-3-alkyl-neptanoyl)-d-gamma-glutamyl-glycyl-d-alanin

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees